VOAV had an obvious inhibiting effects on inflammation, but the percentage of CD4+CD25+Foxp3+ Treg cells in the WEAV-treated IBD group were significantly higher than VOAV. This evidence concerns the gene CD4 and inflammatory bowel disease.